TCL Archive Conversation with The Cancer Letter: UT System Vice Chancellor Shine Describes Rationale for Granting Waiver to DePinho October 26, 2012
TCL Archive Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation June 29, 2012
TCL Archive FDA to elevate oncology to office level, consolidate most cancer programs. Search planned for oncologist to head new office. July 23, 2004
TCL Archive Organ Systems Program Defenders Go On Offense At NCAB Committee Meeting December 11, 1987
